Norwegian Cruise Line (NYSE:NCLH – Free Report) had its price objective increased by Wells Fargo & Company from $21.00 to $27.00 in a report released on Friday, Benzinga reports. They currently have an equal weight rating on the stock.
Several other analysts have also recently issued reports on the company. Susquehanna upped their price objective on Norwegian Cruise Line from $18.00 to $19.00 and gave the stock a “neutral” rating in a report on Friday, August 2nd. Tigress Financial reiterated a “strong-buy” rating and issued a $32.00 target price on shares of Norwegian Cruise Line in a report on Friday, August 9th. Stifel Nicolaus lifted their price objective on shares of Norwegian Cruise Line from $27.00 to $29.00 and gave the stock a “buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. raised their target price on shares of Norwegian Cruise Line from $23.00 to $25.00 and gave the stock a “neutral” rating in a report on Monday, September 16th. Finally, StockNews.com lowered Norwegian Cruise Line from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Norwegian Cruise Line has an average rating of “Hold” and an average price target of $25.80.
Get Our Latest Stock Report on NCLH
Norwegian Cruise Line Stock Up 1.1 %
Norwegian Cruise Line (NYSE:NCLH – Get Free Report) last issued its earnings results on Thursday, October 31st. The company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.05. The business had revenue of $2.81 billion during the quarter, compared to analyst estimates of $2.77 billion. Norwegian Cruise Line had a return on equity of 99.31% and a net margin of 5.87%. Norwegian Cruise Line’s revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.71 EPS. Analysts predict that Norwegian Cruise Line will post 1.65 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in NCLH. Transcendent Capital Group LLC purchased a new stake in shares of Norwegian Cruise Line in the first quarter worth about $27,000. Sentry Investment Management LLC purchased a new stake in Norwegian Cruise Line during the second quarter worth $39,000. Blue Trust Inc. increased its holdings in Norwegian Cruise Line by 489.8% in the third quarter. Blue Trust Inc. now owns 2,188 shares of the company’s stock valued at $41,000 after buying an additional 1,817 shares in the last quarter. Fidelis Capital Partners LLC acquired a new stake in shares of Norwegian Cruise Line during the 1st quarter valued at about $61,000. Finally, Moisand Fitzgerald Tamayo LLC acquired a new position in Norwegian Cruise Line in the 3rd quarter worth about $78,000. 69.58% of the stock is currently owned by institutional investors and hedge funds.
Norwegian Cruise Line Company Profile
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean.
Featured Articles
- Five stocks we like better than Norwegian Cruise Line
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Intel: Is Now the Time to Be Brave?Â
- When to Sell a Stock for Profit or Loss
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is the Nasdaq? Complete Overview with History
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Norwegian Cruise Line Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Norwegian Cruise Line and related companies with MarketBeat.com's FREE daily email newsletter.